These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9751408)
41. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia. Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584 [TBL] [Abstract][Full Text] [Related]
42. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications. Matthews P; Jones CJ; Skinner J; Haughton M; de Micco C; Wynford-Thomas D J Pathol; 2001 Jun; 194(2):183-93. PubMed ID: 11400147 [TBL] [Abstract][Full Text] [Related]
43. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Gokden N; Roehl KA; Catalona WJ; Humphrey PA Urology; 2005 Mar; 65(3):538-42. PubMed ID: 15780372 [TBL] [Abstract][Full Text] [Related]
44. Detection of telomerase activity in prostate cancer by needle biopsy. Takahashi C; Miyagawa I; Kumano S; Oshimura M Eur Urol; 1997; 32(4):494-8. PubMed ID: 9412813 [TBL] [Abstract][Full Text] [Related]
45. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer. Wullich B; Rohde V; Oehlenschläger B; Bonkhoff H; Ketter R; Zwergel T; Sattler HP J Urol; 1999 Jun; 161(6):1997-2001. PubMed ID: 10332489 [TBL] [Abstract][Full Text] [Related]
46. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens. Yasunaga Y; Shin M; Fujita MQ; Nonomura N; Miki T; Okuyama A; Aozasa K Lab Invest; 1998 Oct; 78(10):1275-9. PubMed ID: 9800953 [TBL] [Abstract][Full Text] [Related]
47. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Kojima H; Miyazaki H; Shiwa M; Tanaka Y; Moriyama H Laryngoscope; 2001 May; 111(5):867-73. PubMed ID: 11359168 [TBL] [Abstract][Full Text] [Related]
48. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. Park S; Shinohara K; Grossfeld GD; Carroll PR J Urol; 2001 May; 165(5):1409-14. PubMed ID: 11342887 [TBL] [Abstract][Full Text] [Related]
49. Biologic markers in prostatic intraepithelial neoplasia: immunohistochemical and cytogenetic analyses. Tsuji M; Kanda K; Murakami Y; Kurokawa Y; Kanayama H; Sano T; Kagawa S J Med Invest; 1999 Feb; 46(1-2):35-41. PubMed ID: 10408155 [TBL] [Abstract][Full Text] [Related]
50. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas. Strup SE; Pozzatti RO; Florence CD; Emmert-Buck MR; Duray PH; Liotta LA; Bostwick DG; Linehan WM; Vocke CD J Urol; 1999 Aug; 162(2):590-4. PubMed ID: 10411092 [TBL] [Abstract][Full Text] [Related]
51. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. Epstein JI; Herawi M J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560 [TBL] [Abstract][Full Text] [Related]
52. Telomerase activity in human renal cell carcinoma. Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542 [TBL] [Abstract][Full Text] [Related]
53. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Patton KT; Chen HM; Joseph L; Yang XJ Histopathology; 2005 Dec; 47(6):597-601. PubMed ID: 16324197 [TBL] [Abstract][Full Text] [Related]
54. Telomerase activity in giant cell tumors of bone. Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593 [TBL] [Abstract][Full Text] [Related]
55. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873 [TBL] [Abstract][Full Text] [Related]